December 11, 2024
A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer, a study suggests.
AI-powered blood test first to spot earliest sign of breast cancer
December 5, 2024
Analysis of cheek swabs taken from pregnant women revealed a potential epigenetic biomarker for preeclampsia, a potentially life-threatening condition that often leads to preterm births. While a clinical trial is needed to confirm the results, a study offers hope that a simple test can be developed to identify preeclampsia earlier in pregnancy. Currently preeclampsia is usually identified by symptoms, such as abnormally high blood pressure, which only appear in the second trimester of pregnancy. Sometimes the condition can go undetected until it becomes an emergency.
Potential epigenetic biomarker found for preeclampsia in pregnancy
December 5, 2024
Women who have a high genetic risk of depression are more likely to develop heart disease, researchers have found.
Study exposes link between genetic risk of depression and heart disease in women
December 4, 2024
Research on vaccines may help save more lives.
Model advances rational design of more effective maternal vaccines for newborns
December 4, 2024
When women are pregnant and nurse their babies, their bodies change and various organs, such as the breasts or the immune system, are adapted to ensure the health of both mother and child. This happens throughout evolution in all mammals. An international research team now reports the surprising finding that the intestine also changes completely in pregnant and nursing females, resulting in a doubling of the intestinal surface area and a striking structural reorganization.
Mothers massively change their intestines during pregnancy and nursing
December 4, 2024
A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies.
How breast cancer cells survive in bone marrow after remission
December 4, 2024
Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low-risk tumors have a long-term benefit for at least 20 years, while the benefit was more short-term for younger women with similar tumor characteristics who had not yet gone through the menopause.
Long-term benefit from anti-hormonal treatment is influenced by menopausal status
October 29, 2024
A study suggests that meditation for pain relief may work through different systems in females and males. The results highlight the need for research into different approaches to treating pain depending on sex.
October 29, 2024
Using a highly promising approach to speed breast cancer diagnostics, researcher W. Andy Tao of the Purdue Institute for Cancer Research is studying how specific blood particles could be used to catch BRCA-related breast cancer before any tumor growth.
Purdue News: WGHI-supported research could lead to blood tests for early breast cancer diagnoses
October 25, 2024
A recent article highlights the critical importance of skeletal muscle mass in the context of medically induced weight loss, particularly with the widespread use of GLP-1 receptor agonists. These medications, celebrated for their effectiveness in treating obesity, have raised concerns regarding the potential for substantial muscle loss as part of the weight loss process.
Skeletal muscle health amid growing use of weight loss medications
